Literature DB >> 10065743

CD80 and CD86 costimulatory molecules on circulating T cells of HIV infected individuals.

C Köchli1, T Wendland, K Frutig, R Grunow, S Merlin, W J Pichler.   

Abstract

The expression of CD80 and CD86 costimulatory molecules, typical for antigen presenting cells (APC), was measured on circulating T cells of 20 HIV-infected individuals and of 11 HIV-negative healthy controls. The CD80 and CD86 molecules were present on both circulating T subsets of HIV-infected individuals (mean of CD80 expression within CD4+ T cells [CD80/CD4]: 5.0%; and CD86/CD4: 2.6%; CD80/CD8 4.1% and CD86/CD8: 2.7%) and were associated with HLA-DR expression. Some CD80 and CD86 expression was also found in normal controls, and only the expression of CD86 was significantly (P < 0.05) increased on CD4 + and CD8 + T cells of HIV-infected individuals. The expression of CD28 was decreased on T cells of HIV-infected individuals and was negatively correlated to the expression of HLA-DR and CD86 (mean CD28 within CD3+T cells: HIV+ 29.5%, HIV - 67.6%; correlation coefficient, - 0.75 and - 0.71, respectively). The more the disease proceeds, the less CD28 and the more DR and CD86 are found on circulating T cells. This suggests that during HIV infection T cells themselves develop an antigen presenting phenotype by upregulating expression of HLA-DR, CD86 and CD80 molecules.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10065743     DOI: 10.1016/s0165-2478(98)00107-2

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  7 in total

1.  Enhancement of suboptimal CD8 cytotoxic T cell effector function in vivo using antigen-specific CD80 defective T cells.

Authors:  Irina Puliaeva; Kateryna Soloviova; Maksym Puliaiev; Thomas Lang; Roman Puliaev; Charles S Via
Journal:  J Immunol       Date:  2010-11-29       Impact factor: 5.422

2.  Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions.

Authors:  Geoffrey H Holm; Dana Gabuzda
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes.

Authors:  Adriano Boasso; Andrew W Hardy; Alan L Landay; Jeffrey L Martinson; Stephanie A Anderson; Matthew J Dolan; Mario Clerici; Gene M Shearer
Journal:  Clin Immunol       Date:  2008-07-22       Impact factor: 3.969

Review 4.  PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention.

Authors:  Daniel E Kaufmann; Bruce D Walker
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

5.  Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signaling.

Authors:  Henry Radziewicz; Chris C Ibegbu; Huiming Hon; Nathalie Bédard; Julie Bruneau; Kimberly A Workowski; Stuart J Knechtle; Allan D Kirk; Christian P Larsen; Naglaa H Shoukry; Arash Grakoui
Journal:  J Immunol       Date:  2010-01-25       Impact factor: 5.422

6.  Chronic lymphocytic leukemia (CLL) cells genetically modified to express B7-1, ICAM-1, and LFA-3 confer APC capacity to T cells from CLL patients.

Authors:  Mary T Litzinger; Kenneth A Foon; Helen Sabzevari; Kwong-Yok Tsang; Jeffrey Schlom; Claudia Palena
Journal:  Cancer Immunol Immunother       Date:  2008-11-14       Impact factor: 6.968

7.  Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation.

Authors:  Dagmar Quandt; Simon Jasinski-Bergner; Ulrike Müller; Bianca Schulze; Barbara Seliger
Journal:  J Transl Med       Date:  2014-05-30       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.